Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World

Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World

EXECUTIVE SUMMARY
Acute Wounds
Burns
Chronic Wounds
Products Used in Advanced Wound Management
Film Dressings
Hydrocolloid Dressings
Foam dressings
Alginate Dressings
Hydrogels
Non-Adherent Dressings
Anti-Microbial Dressings
Wound Cleansers and Debriding Agents
Skin Replacements and Substitutes
Pharmacological Products
Physical Therapies
The Market
The Industry


Section 1: BACKGROUND
1.1 Industry Structure
1.2 A Complex Industry
1.3 Major Wound Management Corporations
1.4 Historical Perspective and Technology Breakthroughs
1.5 World-Wide Regulatory and Reimbursement Environment
1.5.1 Cost Effectiveness
1.5.2 Clinical
1.5.3 Regulatory
1.5.4 Reimbursement
1.5.4.1 U.S.A.
1.5.4.2 European Union
1.5.4.3 France
1.5.4.4 Germany
1.5.4.5 United Kingdom
1.5.4.6 Italy
1.5.4.7 Belgium
1.5.4.8 Spain
1.5.4.9 Scandinavia
1.6 Geographical Differences in Treatments of Wounds
1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence
1.8 Wound Management Trends
1.8.1 Surgical Wounds
1.8.2 Traumatic Wounds
1.8.3 Burns
1.8.4 Chronic Wounds
1.9 Market Dynamics


Section 2: CLINICAL BACKGROUND AND CASELOAD
2.1 Background
2.1.1 A few Figures
2.1.2 Overview of Functions
2.1.3 Skin Anatomy: A Summary
2.2 Types of Wounds
2.2.1 Classification By Severity
2.2.2 Classification By Morphology
2.2.3 Classification By Etiology
2.2.4 Color Classification
2.3 Surgical Wounds
2.4 Traumatic Wounds
2.5 Burns
2.5.1 Debridement
2.5.2 Grafting
2.6 Pressure Ulcers
2.6.1 Ulcer Classification
2.6.2 Hospital-Acquired Ulcers
2.6.3 Management of Pressure Ulcers
2.7 Venous Ulcers
2.8 Arterial Ulcers
2.9 Diabetic Ulcers
2.9.1 Prevalence
2.9.2 Stages of Diabetic Ulcer
2.9.3 Treatment
2.9.3.1 Amputations
2.9.3.2 Abnormal Scarring
2.9.4 Acquired Immunodeficiency Syndrome
2.10 Wound Healing Physiology
2.10.1 Inflammatory Phase
2.10.2 Proliferative Phase
2.10.2.1 Angiogenesis
2.10.3 Maturation Phase
2.11 Factors Affecting Wound Healing
2.11.1 Extrinsic Factors
2.11.2 Mechanical Stress
2.11.3 Debris
2.11.4 Temperature
2.11.5 Desiccation and Maceration
2.11.6 Infection
2.11.7 Chemical Stress
2.11.8 Medication
2.11.9 Other Extrinsic Factors
2.11.10 Intrinsic Factors
2.11.11 Health Status
2.11.12 Age Factors
2.11.13 Body Build
2.11.14 Nutritional Status
2.12 Major Treatment Categories and Regimes
2.13 Incidence of Treatments, Growth Rates and Trends


Section 3: PRODUCTS, TECHNOLOGIES AND MARKETS
3.1 Background
3.2 Film Dressings
3.2.1 Overview
3.2.2 Product Examples
3.2.3 Market and Competitive Activity
3.3 Hydrocolloids
3.3.1 Overview
3.3.2 Product Examples
3.3.3 Market and Competitive Activity
3.4 Foam Dressings
3.4.1 Overview
3.4.2 Product Examples
3.4.3 Market and Competitive Activity
3.5 Alginate Dressings
3.5.1 Overview
3.5.2 Product Examples
3.5.3 Market and Competitive Activity
3.6 Hydrogels
3.6.1 Overview
3.6.2 Product Examples
3.6.3 Market and Competitive Activity
3.7 Non Adherent Dressings
3.7.1 Overview
3.7.2 Product Examples
3.7.3 Market and Competitive Activity
3.8 Antimicrobial Dressings
3.8.1 Overview
3.8.2 Product Examples
3.8.3 Market and Competitive Activity
3.9 Tissue Engineered Products
3.9.1 Overview
3.9.2 Traditional skin grafts
3.9.3 Skin replacements
3.9.4 Product Examples
3.9.5 Market and Competitive Analysis
3.10 Pharmacological Products
3.10.1 Overview
3.10.2 Product Examples
3.10.2.1 Growth Factors
3.10.2.2 Growth factors: background
3.10.2.3 Classification
3.10.2.4 Regranex
3.10.2.5 Other Growth Factors
3.10.2.6 Non-Growth Factor Modulators
3.10.3 Market and Competitive Analysis
3.10.3.1 Growth Factors
3.10.3.2 Non-Growth Factor Stimulants
3.10.3.3 Gene Therapy
3.11 Physical Treatments
3.11.1 Negative Pressure Devices
3.11.2 Positive Pressure Devices
3.11.3 Mechanically-assisted Wound Closure
3.11.4 Other Physical Wound Therapies
3.11.4.1 Hydrotherapy
3.11.4.2 Electrical Stimulation
3.11.4.3 Electromagnetic Stimulation Devices
3.11.4.4 Ultraviolet Therapy
3.11.4.5 Hyperbaric Oxygen Therapy
3.11.4.6 Ultrasound Devices
3.11.4.7 Laser Devices
3.11.4.8 Wound Imaging/Documentation
3.11.5 Market and Competitive Analysis
3.11.5.1 Pressure Relief Devices
3.11.5.2 Hydrotherapy
3.11.5.3 Electrical Stimulation
3.11.5.4 Hyperbaric Oxygen Therapy


Section 4: Country Market Analysis
4.1 Global Overview
4.2 Market Estimates
4.2.1 Market Potential
4.2.2 Leading Wound Care Companies
4.2.3 Leading National Markets
4.3 USA
4.3.1 Market Opportunity
4.3.2 Market for Advanced Wound Management Products
4.4 Japan
4.4.1 Wound Care Market
4.4.2 Market Opportunity
4.4.3 Leading Companies
4.5 Germany
4.5.1 Wound Care Market
4.5.2 Leading Companies
4.6 France
4.6.1 Wound Care Market
4.6.2 Leading Companies
4.7 Italy
4.7.1 Wound Care Market
4.7.2 Leading Companies
4.8 United Kingdom
4.8.1 Wound Care Market
4.8.2 Leading Companies


Section 5: COMPANY PROFILES
5.1 Major Companies
5.1.1 Carrington Laboratories Inc.
5.1.2 Coloplast Group
5.1.2.1 Financials
5.1.3 ConvaTec Inc.
5.1.4 Covidien
5.1.4.1 Kendall
5.1.4.2 Financial data
5.1.5 Derma Sciences Inc.
5.1.5.1 Financials
5.1.6 DeRoyal Industries Inc.
5.1.7 Ethicon (Johnson & Johnson)
5.1.8 Gentell Inc.
5.1.9 Geritrex Corp.
5.1.10 Hartmann Group
5.1.11 Hollister Incorporated
5.1.12 Lohmann and Rauscher International GmbH and Co. KG
5.1.13 Medline Industries
5.1.13.1 Advanced Wound Care Products
5.1.14 3M Group
5.1.14.1 Financial data
5.1.15 Mölnlycke Health Care AB
5.1.16 Smith and Nephew Group
5.1.16.1 Financial data
5.1.17 UDL Laboratories (Mylan Labs.)
5.2 Specialist Companies
5.2.1 Antimicrobial Dressings
5.2.1.1 Acrymed Inc.
5.2.1.2 Argentum Products LLC
5.2.1.3 Microban International Ltd
5.2.2 Oxygen Therapy
5.2.2.1 Perry Baromedical Corp.
5.2.3 Tissue Regeneration
5.2.3.1 Advanced BioHealing
5.2.3.2 BioTissue Technologies AG
5.2.3.3 Celltran Limited
5.2.3.4 Fidia Group
5.2.3.5 Genzyme Biosurgery
5.2.3.6 Innogenetics
5.2.3.7 Integra Life Sciences Inc.
5.2.3.8 IsoTis S.A
5.2.3.9 Modex Therapeutics
5.2.3.10 Organogenesis Inc.
5.2.3.11 Ortec International Inc.
5.2.4 Negative Pressure Wound Therapy
5.2.4.1 Kinetic Concepts Inc.
5.2.4.2 BlueSky Medical Group (Smith & Nephew)
5.2.5 Growth Factors
5.2.5.1 E.S. Cell International
5.2.6 Electrical Therapies
5.2.6.1 BioMedical Life Systems Inc
5.2.6.2 Diapulse Corp of America
5.2.6.3 Electromedical Products International Inc.
5.2.6.4 Globalcare Medical
5.2.6.5 Microvas Technologies
5.2.7 Odor Control
5.2.7.1 CliniMed
5.2.8 Other Therapeutic Modalities
5.2.8.1 AGT Sciences Ltd
5.2.8.2 Agennix
5.2.8.3 Advanced Medical Solutions Group plc
5.2.8.4 Anodyne Therapy LLC
5.2.8.5 Applied Tissue Technologies
5.2.8.6 Roho Inc.
5.2.9 Summary Profiles
5.2.9.1 AciesHealth
5.2.9.2 Bard Medical Division
5.2.9.3 Biocore Medical Technologies Inc.
5.2.9.4 Biomarin Pharmaceuticals Inc.
5.2.9.5 Brennen Medical Inc.
5.2.9.6 Dermacor Inc.
5.2.9.7 Derma Rite Industries LLC
5.2.9.8 Encelle Inc.
5.2.9.9 Ferris Manufacturing Corp.
5.2.9.10 Fibrogen
5.2.9.11 Geistlich Pharma
5.2.9.12 HemCon Inc
5.2.9.13 Hymed Group Corporation
5.2.9.14 Innocol, Inc.
5.2.9.15 Integra Life Sciences Holdings Corp.
5.2.9.16 Laboratoires Urgo
5.2.9.17 L.A.M. Pharmaceutical Corp.
5.2.9.18 Lifewave Ltd
5.2.9.19 Longport Inc.
5.2.9.20 Nagor Ltd.
5.2.9.21 SSL International Plc
5.2.9.22 Swiss American Products, Inc.
5.2.9.22.1 Wound Care Products


Appendix: LIST OF COMPANIES


List of Exhibits

Exhibit ES-1: Advanced Wound Care Market, by Segment, 2007 & 2016
Exihbit ES-2: Advanced Wound Care Market Shares by Competitor, 2007

Exhibit 1-1: Worldwide Wound Incidence by Etiology, 2007
Exhibit 1-2: Advanced Wound Management, Worldwide Market Forecast, 2007-2016
Exhibit 1-3: Total World Wound Management Products, Market Forecast, 2005-2014

Exhibit 2-1: Classification of Wounds by Etiology
Exhibit 2-2: Old and New Classification Systems for Burns
Exhibit 2-3: Distribution of Pressure Ulcers

Exhibit 3-1: Companies and Products in the Film Dressings Category
Exhibit 3-2: Film Dressings, Worldwide Market Forecast, 2007-2016
Exhibit 3-3: Film Dressings, Worldwide Market Share by Supplier, 2007
Exhibit 3-4: Companies and Products in the Hydrocolloid Dressings Category
Exhibit 3-5: Hydrocolloid Dressings, Worldwide Market Forecast, 2007-2016
Exhibit 3-6: Hydrocolloid Dressings, Worldwide Market Share by Supplier, 2007
Exhibit 3-7: Companies and Products in the Foam Dressings Category
Exhibit 3-8: Foam Dressings, Worldwide Market Forecast, 2007-2016
Exhibit 3-9: Foam Dressings, Worldwide Market Share by Supplier, 2007
Exhibit 3-10: Companies and Products in the Alginate Dressings Category
Exhibit 3-11: Alginate Dressings, Worldwide Market Forecast, 2007-2016
Exhibit 3-12: Alginate Dressings, Worldwide Market Share by Supplier, 2007
Exhibit 3-13: Amorphous Hydrogels - Companies and Products
Exhibit 3-14: Impregnated Hydrogels – Companies and Products
Exhibit 3-15: Sheet Hydrogels -Companies and Products
Exhibit 3-16: Hydrogel Dressings, Worldwide Market Forecast, 2007- 2016
Exhibit 3-17: Hydrogel Dressings, Worldwide Market Share by Supplier, 2007
Exhibit 3-18: Companies and Products in the Non-Adherent Dressings Category
Exhibit 3-19: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Forecast, 2007-2016
Exhibit 3-20: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Share by Supplier, 2007
Exhibit 3-21: Companies and Products in the Dressings Category
Exhibit 3-22: Antimicrobial Dressings, Worldwide Market Forecast, 2007-2016
Exhibit 3-23: Antimicrobial Dressings, Worldwide Market Share by Supplier, 2007
Exhibit 3-24: Companies and Products in the Tissue Engineering Category
Exhibit 3-25: Skin Tissue Engineering Market, Worldwide Market Forecast, 2007-2016
Exhibit 3-26: Tissue Engineering, Worldwide Share by Supplier, 2007
Exhibit 3-27: Growth Factors in Wound Care, Worldwide Market Forecast, 2007-2016
Exhibit 3-28: Companies Commercializing Technologies in the Physical Active Treatments Category
Exhibit 3-29: Physical Wound Therapies, Worldwide Market Forecast, 2007-2016

Exhibit 4-1: Summary Market Forecasts for Major Advanced Wound Management Product Groups, 2007-2016
Exhibit 4-2: Leading Global Wound Care Companies
Exhibit 4-3: Leading Global Wound Care Companies, Market Share 2007
Exhibit 4-4: National Shares of the Global Advanced Wound Management Market, 2007
Exhibit 4-5: Forecast U.S. Sales for Advanced Wound Management Products for the Period 2007-2016
Exhibit 4-6: Forecast U.S. Sales Growth for the Main Types of Advanced Wound Management Products for the Period 2007-2016
Exhibit 4-7: Japanese Sales for Advanced Wound Management Products for the Period 2007-2016
Exhibit 4-8: Japanese Sales Growth for the Main Types of Advanced Wound Management Products for the Period 2007-2016
Exhibit 4-9: German Sales for Advanced Wound Management Products for the Period 2007-2016
Exhibit 4-10: German Sales Growth for the Main Types of Advanced Wound Management Products for the Period 2007-2016
Exhibit 4-11: French Sales for Advanced Wound Management Products for the period 2007-2016
Exhibit 4-12: French Sales Growth for the Main Types of Advanced Wound Management Products for the Period 2007-2016: $ millions
Exhibit 4-13: Italian Sales for Advanced Wound Management Products for the Period 2007-2016: $ millions
Exhibit 4-14: Italian Sales Growth for the Main Types of Advanced Wound Management Products for the period 2007-2016: $millions
Exhibit 4-15: UK Sales for Advanced Wound Management Products for the Period 2007-2016
Exhibit 4-16: UK Sales Growth for the Main Types of Advanced Wound Management Products for the Period 2007-2016

Exhibit 5-1: Carrington Laboratories Financial Highlights
Exhibit 5-2: Coloplast Revenue Growth by Business Area
Exhibit 5-3: Derma Sciences, 1st Quarter 2007
Exhibit 5-4: Johnson & Johnson Member Companies
Exhibit 5-5: Ethicon Sales, 2004-2006; $ millions
Exhibit 5-6: Hartmann Historic Sales and Profit Data, Reported in €’000
Exhibit 5-7: 3M Healthcare
Exhibit 5-8: Mölnlycke Health Care AB Revenues
Exhibit 5-9: Smith & Nephew Financials, Q1-Q3, 2007
Exhibit 5-10: Recent Top-Line Financial Data for Mylan
Exhibit 5-11: Advanced Wound Management Products and Suppliers